It’s that time of the year, when the industry and academia blend together to be part of a carnival of national and state level conferences and seminars, to contemplate on the future clinical advancements.
Year on year, Transasia Bio-Medicals Ltd, India’s leading IVD Company, has been an active contributor; by bringing together its subject experts as well exhibiting its latest systems, all in an effort to pave the way for better healthcare outcomes.
Held between 24th – 27th October at Goa, the 45th National Conference of Association of Clinical Biochemists of India (ACBICON) hosted faculty from across the world, who shared their expertise on varied topics of interest such as cancer genomics, micro RNAs as novel biomarkers and tools for personalized cancer diagnostics, amongst others. Around the same time, the 43rd Annual Conference of Indian Society of Blood Transfusion and Immunohematology (TRANSCON 2018) a dedicated platform for transfusion medicine specialists, was held from the 26-28th October at Vizag. As a principal partner at both events, Transasia welcomed some of the leading names from the IVD industry for insightful discussions at its booth.
Additionally, at ACBICON it also exhibited some of its best clinical chemistry solutions, offering a throughput from 200 – 1000 tests/ hr. On the other hand, at TRANSCON, it showcased its complete range of blood banking solutions, right from its ELISA panels to fully automated processors for efficient workflow management. Among the very few companies who offer ELISA panels for Transfusion Transmitted Infections (TTI), Transasia’s portfolio is targeted to all the five important infections (HIV, HCV, HbsAg, Syphilis and Malaria). Besides this, it also offers ELISA panel and rapid test kits for dengue and malaria. Moreover, Transasia also announced its soon to be launched rapid test kit for Syphilis. Both the events received an overwhelming response from over 300 delegates from across India.
